Shardul Kulkarni of Angel Broking is of the view that Sun Pharmaceutical Industries may fall to Rs 440. "Going forward we will see further decline in case of Sun Pharma. The stock has already given a breakdown, has now moved into a lower top, lower bottom cycle on the daily chart," he adds.
first published: Aug 21, 2013 05:40 pm
A collection of the most-viewed Moneycontrol videos.
Point-to-Point vs Rolling Returns for Mutual Funds: Full Breakdown
From Hesitant Heir to Undisputed Leader: Sanjiv Bajaj's Leadership Story
Nifty Fails To Defend 26,000 Amid Sluggish Start To Final Week Of 2025| Closing Bell Live
Nifty Aims To Defend 26,000 Amid Thin Volumes, Record-Low VIX| Opening Bell Live
